Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An exploratory clinical trial for combination wound therapy with a novel medical matrix and fibroblast growth factor in patients with chronic skin ulcers: a study protocol.
Morimoto N, Yoshimura K, Niimi M, Ito T, Tada H, Teramukai S, Murayama T, Toyooka C, Takemoto S, Kawai K, Yokode M, Shimizu A, Suzuki S. Morimoto N, et al. Among authors: murayama t. Am J Transl Res. 2012;4(1):52-9. Epub 2012 Jan 5. Am J Transl Res. 2012. PMID: 22347522 Free PMC article.
Novel collagen/gelatin scaffold with sustained release of basic fibroblast growth factor: clinical trial for chronic skin ulcers.
Morimoto N, Yoshimura K, Niimi M, Ito T, Aya R, Fujitaka J, Tada H, Teramukai S, Murayama T, Toyooka C, Miura K, Takemoto S, Kanda N, Kawai K, Yokode M, Shimizu A, Suzuki S. Morimoto N, et al. Among authors: murayama t. Tissue Eng Part A. 2013 Sep;19(17-18):1931-40. doi: 10.1089/ten.tea.2012.0634. Epub 2013 Apr 27. Tissue Eng Part A. 2013. PMID: 23541061 Free article. Clinical Trial.
Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: a phase I/II clinical trial, following preclinical studies to ensure safety.
Ido A, Moriuchi A, Numata M, Murayama T, Teramukai S, Marusawa H, Yamaji N, Setoyama H, Kim ID, Chiba T, Higuchi S, Yokode M, Fukushima M, Shimizu A, Tsubouchi H. Ido A, et al. Among authors: murayama t. J Transl Med. 2011 May 8;9:55. doi: 10.1186/1479-5876-9-55. J Transl Med. 2011. PMID: 21548996 Free PMC article. Clinical Trial.
A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head.
Kuroda Y, Asada R, So K, Yonezawa A, Nankaku M, Mukai K, Ito-Ihara T, Tada H, Yamamoto M, Murayama T, Morita S, Tabata Y, Yokode M, Shimizu A, Matsuda S, Akiyama H. Kuroda Y, et al. Among authors: murayama t. Int Orthop. 2016 Aug;40(8):1747-1754. doi: 10.1007/s00264-015-3083-1. Epub 2015 Dec 29. Int Orthop. 2016. PMID: 26715504 Free article.
Safety and efficacy of sustained release of basic fibroblast growth factor using gelatin hydrogel in patients with critical limb ischemia.
Kumagai M, Marui A, Tabata Y, Takeda T, Yamamoto M, Yonezawa A, Tanaka S, Yanagi S, Ito-Ihara T, Ikeda T, Murayama T, Teramukai S, Katsura T, Matsubara K, Kawakami K, Yokode M, Shimizu A, Sakata R. Kumagai M, et al. Among authors: murayama t. Heart Vessels. 2016 May;31(5):713-21. doi: 10.1007/s00380-015-0677-x. Epub 2015 Apr 11. Heart Vessels. 2016. PMID: 25861983 Clinical Trial.
1,144 results